Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-07-15

Clinical Trial Update: Evaluation of Safety and Efficacy of Mersina, an Ayurvedic Formulation: A Double Blind, Placebo Controlled Study in Type 2 Diabetic Patients With Secondary Failure to Oral Drugs [Phase 2]

View source ↗

Summary

Phase 2 double-blind, placebo-controlled trial evaluating the safety and efficacy of Mersina in type 2 diabetes mellitus patients with secondary failure to oral…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mersina

Snippet

Sponsor: Jyoti Clinical and Pathological Laboratory | Conditions: Antihyperglycemic Effect in Type 2 Diabetic Patients With Secondary Failure to Oral Hypoglycemic Agents | Phase 2 | Status: COMPLETED